Contact Us

Contact Us

Please contact us below with any questions

info@quadratech.co.uk

+44 (0)33 3321 2371

Side Contact
×
Sign up to our newsletter Click Here
quadratech Logo
{{ toggleHam ? 'CLOSE' : 'MENU' }}
Next Day & International Delivery
Competitive Pricing
Over 30 Years Experience
Based In The UK

55th Annual Meeting Society of Thrombosis and Haemostasis Research – [TF]

Aim: Among microparticles (MP) those exposing Tissue Factor (TF) are of particular interest, for their critical role in the initiation of thrombosis. They may be a useful biomarker to identify an increased risk of thrombosis in various pathologies (e.g. cancer). We developed the Zymuphen MP-TF method, an ultra sensitive bio-immunoassay that allows the determination of MP-TF procoagulant activity in human plasma.

Method: Plasmas are prepared using a double centrifugation at Room Temperature (low and high speed) to eliminate platelets. MP-TFs are captured by a murine MoAb directed against the extracellular domain of TF, that does not inhibit TF activity. Following a washing step, FVIIa and F X are added into the reaction mixture. TF-FVIIa complexes form and activate F X into F Xa (FXa) in presence of Ca++. FXa generation is dependent on TF and MP’s anionic phospholipids concentration. Then a FXa-specific substrate (CS 11(65)) is added, reacts with FXa, releasing pNA, which absorbance is recorded at 405nm. A lyophilized calibrator, containing rec.(h) TF relipidated with synthetic phospholipids, permits the standardization of the assay. Calibration is from 0 to 5 pg/ml of TF equivalent, with a ratio of 0.1 nM PS/ 1 pg TF.

Results: Normals were < 0.2 pg/ml, while 2 pathological plasmas that were found to have high MPs concentration (9.8 and >63 nM PS) with Zymuphen MP Activity, were found at 0.95 pg/ml and > 5 pg/ml using Zymuphen MP-TF. Plasmas from LPS-stimulated whole blood following a 6 hour incubation were significantly higher than baseline (t=0h) with a MP-TF generation ranging from 5 to 22 μg/ml. Recombinant Truncated TF (1-219), when mixed at 100 pg/ml with synthetic saturating phospholipids (870nM PS), was < 0.2 pg/ml demonstrating the specificity for MP-TF.

Conclusion: Zymuphen MP-TF is a highly sensitive and specific method for the measurement of MP-TF in citrated plasma, and is a useful for assessing the clinical interest of this biomarker in pathology.

 

Our Accreditations

Cookie Consent

Cookies help us deliver our services. By using our services, you agree to our use of cookies.